This reporting guide on HIV/AIDS in India is designed for journalists covering the global epidemic, often on short notice. The Kaiser Family Foundation undertook this project as part of its continuing commitment to combating HIV/AIDS through public education and awareness. The material covers a broad range of subjects including the science, treatment and prevention of HIV/AIDS. The epidemic is not only a battle against a virus. It can also be a battle about ideas, cultural taboos, stigma and discrimination. For that reason, we have included information about the political and social aspects of the epidemic. For example, we describe language that may, inadvertently, promote discrimination and suggest alternatives. You should view this as a reference guide. A more in-depth source of information on HIV/AIDS can be found in the HIV/AIDS section of this website. Kaiser has always believed that journalists have a significant role to play in informing the public and public policy officials. This reporting guide, we hope, will contribute to that process. This manual was last updated in July 2008.

 Full Manual (.pdf)

      Section 1: Acronyms (.pdf)

      Section 2: Glossary (.pdf)

      Section 3: Changing face of India's epidemic (.pdf)

      Section 4: Laws are necessary to protect rights (.pdf)

      Section 5: Timeline of HIV/AIDS in India (.pdf)

      Section 6: The Numbers game: Story behind estimates (.pdf)

      Section 7: Timeline International (.pdf)

      Section 8: Ethics in Reporting on HIV/AIDS (.pdf)

      Section 9: Gender Sensitive reporting on HIV/AIDS (.pdf)

      Section 10: FAQs About HIV/AIDS (.pdf)

      Section 11: HIV Prevention (.pdf)

      Section 12: HIV/AIDS Information on the Internet (.pdf)

      Section 13: FAQs on Covering HIV/AIDS (.pdf)

      Section 14: Sensitive Language (.pdf)

      Section 15: Understanding and reporting on HIV/AIDS data (.pdf)

      Section 16: Anti-Retroviral Drugs in India (.pdf)

      Section 17: Guide to drug development and approval (.pdf)

      Section 18: FAQs on Patents (.pdf)

      Section 19: Important Terms in Antiretroviral Therapy (.pdf)

      Section 20: Global Goals and Financial Commitments (.pdf)

      Section 21: Opportunistic Infections (.pdf)

      Section 22: India Contacts (.pdf)

      Section 23: Key Figures (.pdf)